<p>Cardlytics（納斯達克股票代碼：CDLX - 獲取免費報告）在週三的研究報告中被 Craig Hallum 的股票分析師從 “持有” 評級上調至 “強力買入” 評級，Zacks.com 報道。</p>
<p>其他一些分析師最近也對 CDLX 發佈了報告。Lake Street Capital 將 Cardlytics 的評級從 “買入” 下調至 “持有”，並將其股票目標價從 18.00 美元下調至 5.00 美元，報告日期為 8 月 8 日，星期四。Evercore ISI 在 10 月 11 日，星期五開始對 Cardlytics 進行覆蓋，給予 “持平” 評級和 4.00 美元的目標價。Northland Securities 將 Cardlytics 的評級從 “跑贏大盤” 下調至 “市場表現”，並將其股票目標價從 7.00 美元下調至 5.00 美元，報告日期為 8 月 16 日，星期五。美國銀行將 Cardlytics 的評級從 “中性” 下調至 “表現不佳”，並將其股票目標價從 4.00 美元下調至 3.50 美元，報告日期為 8 月 15 日，星期四。最後，Needham &amp; Company LLC 在週四的報告中重申了對 Cardlytics 股票的 “持有” 評級。一位投資分析師給予該股票 “賣出” 評級，五位分析師給予 “持有” 評級，一位分析師給予 “強力買入” 評級。根據 MarketBeat 的數據，該公司的平均評級為 “持有”，共識目標價為 6.92 美元。</p>
<p><strong>查看我們對 Cardlytics 的最新分析</strong></p>
<h2>Cardlytics 股票下跌 21.9%</h2>
<p>CDLX 的股票在週三以 4.07 美元開盤。該公司的 50 日移動平均線為 3.68 美元，200 日移動平均線為 6.76 美元。公司市值為 2.0285 億美元，市盈率為-1.06，貝塔值為 1.61。Cardlytics 的 12 個月低點為 2.89 美元，12 個月高點為 20.52 美元。該公司的流動比率為 1.77，速動比率為 1.77，債務與股本比率為 1.01。</p>
<p>Cardlytics（納斯達克股票代碼：CDLX - 獲取免費報告）最近在 8 月 7 日，星期三發佈了季度財報。公司報告每股收益（EPS）為-0.09 美元，超出分析師的共識預期（-0.21 美元）0.12 美元。Cardlytics 的股本回報率為-17.96%，淨利潤率為-50.21%。該公司季度收入為 6964 萬美元，而共識預期為 7539 萬美元。在去年同期，該公司每股收益為-0.57 美元。與去年同期相比，該公司的收入下降了 9.2%。研究分析師預計 Cardlytics 在當前財年將發佈-1.72 美元的每股收益。</p>
<h2>Cardlytics 內部活動</h2>
<p>在其他 Cardlytics 的新聞中，董事 Scott A. Hill 在 8 月 12 日，星期一以每股平均價格 3.58 美元購買了 40,000 股公司的股票，總交易額為 143,200.00 美元。收購後，該董事現在直接持有 40,000 股公司股票，價值 143,200 美元。該交易已在向證券交易委員會提交的文件中披露，文件可通過此鏈接獲取。在其他新聞中，首席執行官 Amit Gupta 在 10 月 24 日，星期四出售了 22,607 股股票，出售價格為每股 3.85 美元，總交易額為 87,036.95 美元。交易後，首席執行官現在持有 178,519 股公司股票，價值約 687,298.15 美元。這代表其持股比例下降了 0.00%。該交易已在向證券交易委員會提交的文件中披露，文件可通過此鏈接獲取。此外，董事 Scott A. Hill 在 8 月 12 日，星期一以每股平均價格 3.58 美元購買了 40,000 股公司的股票，總交易額為 143,200.00 美元。交易後，該董事現在直接持有 40,000 股公司股票，價值約 143,200 美元。該購買的披露信息可在此處找到。內部人士在上個季度共出售了價值 151,612 美元的 43,573 股公司股票。公司內部人士持有 4.40% 的股份。</p>
<h2>對 Cardlytics 的對沖基金看法</h2>
<p>一些對沖基金和其他機構投資者最近對 CDLX 的持倉進行了調整。Canton Hathaway LLC 在第二季度將其在 Cardlytics 的持倉增加了 95.7%。Canton Hathaway LLC 現在持有 4,500 股公司股票，價值 37,000 美元，此前在上個季度又購買了 2,200 股。SG Americas Securities LLC 在第三季度購買了 Cardlytics 的新頭寸，價值 45,000 美元。Creative Planning 在第三季度將其在 Cardlytics 的持倉增加了 35.4%。Creative Planning 現在持有 29,537 股公司股票，價值 95,000 美元，此前在上個季度又購買了 7,721 股。XTX Topco Ltd 在第二季度購買了 Cardlytics 的新頭寸，價值 107,000 美元。最後，Quest Partners LLC 在第二季度將其在 Cardlytics 的持倉增加了 160.4%。Quest Partners LLC 現在持有 17,956 股公司股票，價值 147,000 美元，此前在上個季度又購買了 11,061 股。機構投資者持有公司 68.10% 的股份。</p>
<h2>Cardlytics 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Cardlytics, Inc 在美國和英國運營一個廣告平台。它提供 Cardlytics 平台，這是一個專有的本地銀行廣告渠道，使營銷人員能夠通過其金融機構合作伙伴的網絡通過在線、移動應用程序、電子郵件和各種實時通知等數字渠道接觸客户；以及 Bridg 平台，這是一個客户數據平台，利用銷售點數據，使營銷人員能夠進行分析和針對性忠誠營銷，並衡量其營銷的影響。</p>
<h2>推薦故事</h2>
<ul>
<li>我們更看好的五隻股票，而不是 Cardlytics</li>
<li>每月分紅股票的利弊</li>
<li>吉利德股票飆升：是什麼推動了這一勢頭？</li>
<li>分紅支付比率計算器</li>
<li>突破警報：高通剛剛按下了反彈按鈕</li>
<li>ESG 股票，投資者應該知道什麼</li>
<li>Mercado Libre 股票降價：現在是購買的時機嗎？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0RMWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0RMWA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
<p>→ 前白宮顧問預測拜登退出競選，做出驚人新預測（來自 Paradigm Press）（廣告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDM5Mg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDM5Mg"/></p>
<h2>你現在應該投資 1,000 美元在 Cardlytics 嗎？</h2>
<p>在考慮 Cardlytics 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Cardlytics 並不在名單上。</p>
<p>雖然 Cardlytics 目前在分析師中被評為 “減持”，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

CDLX

<p>Craig Hallum 在最近的一份報告中將 Cardlytics (NASDAQ:CDLX) 的評級從 “持有” 上調至 “強力買入”。其他分析師的看法則不一，Lake Street Capital 將該股票下調至 “持有”，而美國銀行則下調至 “表現不佳”。Cardlytics 的股票開盤價為 0.07 美元，下跌 21.9%，市值為 8500 萬美元。該公司報告的季度每股收益為 -0.09 美元，超出預期，但收入同比下降 9.2%。內部交易活動包括一名董事購買了 40,000 股，首席執行官出售了 22,607 股</p>

<p>Cardlytics (NASDAQ:CDLX - Get Free Report) was upgraded by stock analysts at Craig Hallum from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note issued on Wednesday,Zacks.com reports.</p>
<div class="lb-trans"><p>Cardlytics（納斯達克股票代碼：CDLX - 獲取免費報告）在週三的研究報告中被 Craig Hallum 的股票分析師從 “持有” 評級上調至 “強力買入” 評級，Zacks.com 報道。</p>
</div><p>A number of other analysts also recently issued reports on CDLX. Lake Street Capital downgraded Cardlytics from a &#34;buy&#34; rating to a &#34;hold&#34; rating and reduced their price objective for the stock from $18.00 to $5.00 in a research note on Thursday, August 8th. Evercore ISI began coverage on Cardlytics in a report on Friday, October 11th. They issued an &#34;in-line&#34; rating and a $4.00 target price for the company. Northland Securities cut Cardlytics from an &#34;outperform&#34; rating to a &#34;market perform&#34; rating and dropped their target price for the stock from $7.00 to $5.00 in a report on Friday, August 16th. Bank of America cut Cardlytics from a &#34;neutral&#34; rating to an &#34;underperform&#34; rating and dropped their target price for the stock from $4.00 to $3.50 in a report on Thursday, August 15th. Finally, Needham &amp; Company LLC reiterated a &#34;hold&#34; rating on shares of Cardlytics in a report on Thursday. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of &#34;Hold&#34; and a consensus price target of $6.92.</p>
<div class="lb-trans"><p>其他一些分析師最近也對 CDLX 發佈了報告。Lake Street Capital 將 Cardlytics 的評級從 “買入” 下調至 “持有”，並將其股票目標價從 18.00 美元下調至 5.00 美元，報告日期為 8 月 8 日，星期四。Evercore ISI 在 10 月 11 日，星期五開始對 Cardlytics 進行覆蓋，給予 “持平” 評級和 4.00 美元的目標價。Northland Securities 將 Cardlytics 的評級從 “跑贏大盤” 下調至 “市場表現”，並將其股票目標價從 7.00 美元下調至 5.00 美元，報告日期為 8 月 16 日，星期五。美國銀行將 Cardlytics 的評級從 “中性” 下調至 “表現不佳”，並將其股票目標價從 4.00 美元下調至 3.50 美元，報告日期為 8 月 15 日，星期四。最後，Needham &amp; Company LLC 在週四的報告中重申了對 Cardlytics 股票的 “持有” 評級。一位投資分析師給予該股票 “賣出” 評級，五位分析師給予 “持有” 評級，一位分析師給予 “強力買入” 評級。根據 MarketBeat 的數據，該公司的平均評級為 “持有”，共識目標價為 6.92 美元。</p>
</div><p><strong>Check Out Our Latest Analysis on Cardlytics</strong></p>
<div class="lb-trans"><p><strong>查看我們對 Cardlytics 的最新分析</strong></p>
</div><h2>Cardlytics Stock Down 21.9 %</h2>
<div class="lb-trans"><h2>Cardlytics 股票下跌 21.9%</h2>
</div><p>Shares of CDLX opened at $4.07 on Wednesday. The business's 50 day moving average is $3.68 and its 200 day moving average is $6.76. The company has a market capitalization of $202.85 million, a PE ratio of -1.06 and a beta of 1.61. Cardlytics has a 12-month low of $2.89 and a 12-month high of $20.52. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 1.01.</p>
<div class="lb-trans"><p>CDLX 的股票在週三以 4.07 美元開盤。該公司的 50 日移動平均線為 3.68 美元，200 日移動平均線為 6.76 美元。公司市值為 2.0285 億美元，市盈率為-1.06，貝塔值為 1.61。Cardlytics 的 12 個月低點為 2.89 美元，12 個月高點為 20.52 美元。該公司的流動比率為 1.77，速動比率為 1.77，債務與股本比率為 1.01。</p>
</div><p>Cardlytics (NASDAQ:CDLX - Get Free Report) last released its quarterly earnings data on Wednesday, August 7th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.21) by $0.12. Cardlytics had a negative return on equity of 17.96% and a negative net margin of 50.21%. The business had revenue of $69.64 million for the quarter, compared to the consensus estimate of $75.39 million. During the same quarter in the previous year, the company posted ($0.57) EPS. The company's revenue was down 9.2% compared to the same quarter last year. Research analysts expect that Cardlytics will post -1.72 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Cardlytics（納斯達克股票代碼：CDLX - 獲取免費報告）最近在 8 月 7 日，星期三發佈了季度財報。公司報告每股收益（EPS）為-0.09 美元，超出分析師的共識預期（-0.21 美元）0.12 美元。Cardlytics 的股本回報率為-17.96%，淨利潤率為-50.21%。該公司季度收入為 6964 萬美元，而共識預期為 7539 萬美元。在去年同期，該公司每股收益為-0.57 美元。與去年同期相比，該公司的收入下降了 9.2%。研究分析師預計 Cardlytics 在當前財年將發佈-1.72 美元的每股收益。</p>
</div><h2>Insider Activity at Cardlytics</h2>
<div class="lb-trans"><h2>Cardlytics 內部活動</h2>
</div><p>In other Cardlytics news, Director Scott A. Hill acquired 40,000 shares of the company's stock in a transaction that occurred on Monday, August 12th. The stock was bought at an average price of $3.58 per share, for a total transaction of $143,200.00. Following the acquisition, the director now directly owns 40,000 shares in the company, valued at $143,200. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this hyperlink. In other news, CEO Amit Gupta sold 22,607 shares of the stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $3.85, for a total transaction of $87,036.95. Following the transaction, the chief executive officer now owns 178,519 shares of the company's stock, valued at approximately $687,298.15. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which can be accessed through this link. Also, Director Scott A. Hill purchased 40,000 shares of the company's stock in a transaction dated Monday, August 12th. The shares were purchased at an average cost of $3.58 per share, for a total transaction of $143,200.00. Following the transaction, the director now directly owns 40,000 shares in the company, valued at approximately $143,200. The disclosure for this purchase can be found here. Insiders sold a total of 43,573 shares of company stock worth $151,612 in the last quarter. 4.40% of the stock is owned by company insiders.</p>
<div class="lb-trans"><p>在其他 Cardlytics 的新聞中，董事 Scott A. Hill 在 8 月 12 日，星期一以每股平均價格 3.58 美元購買了 40,000 股公司的股票，總交易額為 143,200.00 美元。收購後，該董事現在直接持有 40,000 股公司股票，價值 143,200 美元。該交易已在向證券交易委員會提交的文件中披露，文件可通過此鏈接獲取。在其他新聞中，首席執行官 Amit Gupta 在 10 月 24 日，星期四出售了 22,607 股股票，出售價格為每股 3.85 美元，總交易額為 87,036.95 美元。交易後，首席執行官現在持有 178,519 股公司股票，價值約 687,298.15 美元。這代表其持股比例下降了 0.00%。該交易已在向證券交易委員會提交的文件中披露，文件可通過此鏈接獲取。此外，董事 Scott A. Hill 在 8 月 12 日，星期一以每股平均價格 3.58 美元購買了 40,000 股公司的股票，總交易額為 143,200.00 美元。交易後，該董事現在直接持有 40,000 股公司股票，價值約 143,200 美元。該購買的披露信息可在此處找到。內部人士在上個季度共出售了價值 151,612 美元的 43,573 股公司股票。公司內部人士持有 4.40% 的股份。</p>
</div><h2>Hedge Funds Weigh In On Cardlytics</h2>
<div class="lb-trans"><h2>對 Cardlytics 的對沖基金看法</h2>
</div><p>A number of hedge funds and other institutional investors have recently made changes to their positions in CDLX. Canton Hathaway LLC grew its position in shares of Cardlytics by 95.7% during the 2nd quarter. Canton Hathaway LLC now owns 4,500 shares of the company's stock worth $37,000 after buying an additional 2,200 shares in the last quarter. SG Americas Securities LLC bought a new position in shares of Cardlytics during the 3rd quarter worth $45,000. Creative Planning grew its position in shares of Cardlytics by 35.4% during the 3rd quarter. Creative Planning now owns 29,537 shares of the company's stock worth $95,000 after buying an additional 7,721 shares in the last quarter. XTX Topco Ltd bought a new position in shares of Cardlytics during the 2nd quarter worth $107,000. Finally, Quest Partners LLC boosted its position in Cardlytics by 160.4% during the second quarter. Quest Partners LLC now owns 17,956 shares of the company's stock valued at $147,000 after purchasing an additional 11,061 shares in the last quarter. Institutional investors own 68.10% of the company's stock.</p>
<div class="lb-trans"><p>一些對沖基金和其他機構投資者最近對 CDLX 的持倉進行了調整。Canton Hathaway LLC 在第二季度將其在 Cardlytics 的持倉增加了 95.7%。Canton Hathaway LLC 現在持有 4,500 股公司股票，價值 37,000 美元，此前在上個季度又購買了 2,200 股。SG Americas Securities LLC 在第三季度購買了 Cardlytics 的新頭寸，價值 45,000 美元。Creative Planning 在第三季度將其在 Cardlytics 的持倉增加了 35.4%。Creative Planning 現在持有 29,537 股公司股票，價值 95,000 美元，此前在上個季度又購買了 7,721 股。XTX Topco Ltd 在第二季度購買了 Cardlytics 的新頭寸，價值 107,000 美元。最後，Quest Partners LLC 在第二季度將其在 Cardlytics 的持倉增加了 160.4%。Quest Partners LLC 現在持有 17,956 股公司股票，價值 147,000 美元，此前在上個季度又購買了 11,061 股。機構投資者持有公司 68.10% 的股份。</p>
</div><h2>Cardlytics Company Profile</h2>
<div class="lb-trans"><h2>Cardlytics 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.</p>
<div class="lb-trans"><p>Cardlytics, Inc 在美國和英國運營一個廣告平台。它提供 Cardlytics 平台，這是一個專有的本地銀行廣告渠道，使營銷人員能夠通過其金融機構合作伙伴的網絡通過在線、移動應用程序、電子郵件和各種實時通知等數字渠道接觸客户；以及 Bridg 平台，這是一個客户數據平台，利用銷售點數據，使營銷人員能夠進行分析和針對性忠誠營銷，並衡量其營銷的影響。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Cardlytics</li>
<li>Pros And Cons Of Monthly Dividend Stocks</li>
<li>Gilead’s Stock Surge: What’s Fueling the Momentum?</li>
<li>Dividend Payout Ratio Calculator</li>
<li>Breakout Alert: Qualcomm Just Hit The Rally Button</li>
<li>ESG Stocks, What Investors Should Know</li>
<li>Mercado Libre Shares Go on Sale: Is Now the Time to Buy?</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而不是 Cardlytics</li>
<li>每月分紅股票的利弊</li>
<li>吉利德股票飆升：是什麼推動了這一勢頭？</li>
<li>分紅支付比率計算器</li>
<li>突破警報：高通剛剛按下了反彈按鈕</li>
<li>ESG 股票，投資者應該知道什麼</li>
<li>Mercado Libre 股票降價：現在是購買的時機嗎？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0RMWA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=CDLX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
</div><p>→ Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction (From Paradigm Press)(Ad)</p>
<div class="lb-trans"><p>→ 前白宮顧問預測拜登退出競選，做出驚人新預測（來自 Paradigm Press）（廣告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDM5Mg" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10392&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Cardlytics right now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Cardlytics 嗎？</h2>
</div><p>Before you consider Cardlytics, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Cardlytics 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardlytics wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Cardlytics 並不在名單上。</p>
</div><p>While Cardlytics currently has a &#34;Reduce&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Cardlytics 目前在分析師中被評為 “減持”，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Cardlytics (NASDAQ:CDLX) 的股票評級被 Craig Hallum 上調